OraSure Technologies, Inc. (FRA:EP3)

Germany · Delayed Price · Currency is EUR

2.320

+0.020 (0.87%)

At close: Jan 30, 2026

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Human Immunodeficiency Virus	60.80M
Human Immunodeficiency Virus Growth	-0.03%
Sample Management Solutions	51.05M
Sample Management Solutions Growth	-5.95%
COVID-19	45.17M
COVID-19 Growth	-82.48%
Hepatitis C Virus	14.02M
Hepatitis C Virus Growth	8.96%
Risk Assessment Testing	8.35M
Risk Assessment Testing Growth	-14.19%
Other Product and Services	3.51M
Other Product and Services Growth	54.79%
Molecular Services	1.71M
Molecular Services Growth	-61.89%
Non-product and Services	1.22M
Non-product and Services Growth	-62.58%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	139.16M
United States Growth	-61.52%
Africa	32.75M
Europe	8.42M
Europe Growth	3.86%
Other Regions	5.50M
Other Regions Growth	-84.60%